メルカプトプリン錠の世界市場に関する洞察、2031年までの予測

当レポートは、メルカプトプリン錠 (Mercaptopurine Tablets) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

• メルカプトプリン錠の製品概要
• 市場：タイプ別
  • 世界のメルカプトプリン錠の市場規模成長率：タイプ別, 2020 VS 2024 VS 2031
  • 25mg
  • 50mg
• 市場：用途別
  • 世界のメルカプトプリン錠の市場規模成長率：用途別, 2020 VS 2024 VS 2031
  • Hospital
  • Clinic
  • Others
• 前提条件と制限
• 調査目的
• 対象期間

第2章 レポート概要

• 世界のメルカプトプリン錠の収益 推定および予測 2020-2031
• 世界の収益：地域別
  • 世界のメルカプトプリン錠 収益：地域別: 2020 VS 2024 VS 2031
  • 世界のメルカプトプリン錠 収益：地域別 (2020-2031)
  • 世界のメルカプトプリン錠の収益市場シェア 地域別 (2020-2031)
• 世界のメルカプトプリン錠 売上予測・予想 2020-2031
• 世界の販売：地域別
  • 世界のメルカプトプリン錠 販売：地域別: 2020 VS 2024 VS 2031
  • 世界のメルカプトプリン錠 販売：地域別 (2020-2031)
  • 世界のメルカプトプリン錠の販売市場シェア 地域別 (2020-2031)
• 米国・カナダ
• 欧州
• 中国
• アジア（中国を除く）
• 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

• 世界の販売：企業別
  • 世界のメルカプトプリン錠 販売：企業別 (2020-2025)
  • 世界のメルカプトプリン錠の販売市場シェア：企業別 (2020-2025)
  • 世界の上位10・上位5企業： メルカプトプリン錠 2024年
• 世界の収益：企業別
  • 世界のメルカプトプリン錠 収益：企業別 (2020-2025)
  • 世界のメルカプトプリン錠の収益市場シェア：企業別 (2020-2025)
  • 世界の上位10・上位5企業： メルカプトプリン錠 収益 2024年
• 世界の主要企業 メルカプトプリン錠, 業界ランキング, 2023 VS 2024
• 世界のメルカプトプリン錠の販売価格：企業別 (2020-2025)
• 競合情勢の分析
  • 企業の市場集中度 (CR5 and HHI)
  • 世界のメルカプトプリン錠の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
• 世界の主要メーカー メルカプトプリン錠, 製造拠点分布と本社
• 世界の主要メーカー メルカプトプリン錠, 提供製品と用途
• 世界の主要メーカー メルカプトプリン錠, 業界参入時期
• M&A, 拡張計画

第4章 市場規模：タイプ別

• 世界の販売：タイプ別
  • 世界のメルカプトプリン錠の販売実績：タイプ別 (2020-2025)
  • 世界のメルカプトプリン錠の販売予測：タイプ別 (2026-2031)
  • 世界のメルカプトプリン錠の販売市場シェア：タイプ別 (2020-2031)
• 世界の収益：タイプ別
  • 世界のメルカプトプリン錠の収益実績：タイプ別 (2020-2025)
  • 世界のメルカプトプリン錠の収益予測：タイプ別 (2026-2031)
  • 世界のメルカプトプリン錠の収益市場シェア：タイプ別 (2020-2031)
• 世界の価格：タイプ別
  • 世界のメルカプトプリン錠 価格：タイプ別 (2020-2025)
  • 世界のメルカプトプリン錠の価格予測：タイプ別 (2026-2031)

第5章 市場規模：用途別

• 世界の販売：用途別
  • 世界のメルカプトプリン錠の販売実績：用途別 (2020-2025)
  • 世界のメルカプトプリン錠の販売予測：用途別 (2026-2031)
  • 世界のメルカプトプリン錠の販売市場シェア：用途別 (2020-2031)
• 世界の収益：用途別
  • 世界のメルカプトプリン錠の収益実績：用途別 (2020-2025)
  • 世界のメルカプトプリン錠の収益予測：用途別 (2026-2031)
  • 世界のメルカプトプリン錠の収益市場シェア：用途別 (2020-2031)
• 世界の価格：用途別
  • 世界のメルカプトプリン錠 価格：用途別 (2020-2025)
  • 世界のメルカプトプリン錠の価格予測：用途別 (2026-2031)

第6章 米国・カナダ

• 米国・カナダ 市場規模：タイプ別
  • 米国・カナダ メルカプトプリン錠 販売：タイプ別 (2020-2031)
  • 米国・カナダ メルカプトプリン錠 収益：タイプ別 (2020-2031)
• 米国・カナダ 市場規模：用途別
  • 米国・カナダ メルカプトプリン錠 販売：用途別 (2020-2031)
  • 米国・カナダ メルカプトプリン錠 収益：用途別 (2020-2031)
• 米国・カナダ 市場規模：国別
  • 米国・カナダ メルカプトプリン錠の収益：国別: 2020 VS 2024 VS 2031
  • 米国・カナダ メルカプトプリン錠の収益：国別 (2020-2031)
  • 米国・カナダ メルカプトプリン錠の販売：国別 (2020-2031)
  • US
  • カナダ

第7章 欧州

• 欧州の市場規模：タイプ別
  • 欧州のメルカプトプリン錠 販売：タイプ別 (2020-2031)
  • 欧州のメルカプトプリン錠 収益：タイプ別 (2020-2031)
• 欧州の市場規模：用途別
  • 欧州のメルカプトプリン錠 販売：用途別 (2020-2031)
  • 欧州のメルカプトプリン錠 収益：用途別 (2020-2031)
• 欧州の市場規模：国別
  • 欧州のメルカプトプリン錠の収益：国別: 2020 VS 2024 VS 2031
  • 欧州のメルカプトプリン錠の販売：国別 (2020-2031)
  • 欧州のメルカプトプリン錠の収益：国別 (2020-2031)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア

第8章 中国

• 中国の市場規模：タイプ別
  • 中国のメルカプトプリン錠 販売：タイプ別 (2020-2031)
  • 中国のメルカプトプリン錠 収益：タイプ別 (2020-2031)
• 中国の市場規模：用途別
  • 中国のメルカプトプリン錠 販売：用途別 (2020-2031)
  • 中国のメルカプトプリン錠 収益：用途別 (2020-2031)

第9章 アジア（中国を除く）

• アジア地域 市場規模：タイプ別
  • アジア地域 メルカプトプリン錠 販売：タイプ別 (2020-2031)
  • アジア地域 メルカプトプリン錠 収益：タイプ別 (2020-2031)
• アジア地域 市場規模：用途別
  • アジア地域 メルカプトプリン錠 販売：用途別 (2020-2031)
  • アジア地域 メルカプトプリン錠 収益：用途別 (2020-2031)
• アジア地域 市場規模：地域別
  • アジア地域 メルカプトプリン錠 収益：地域別: 2020 VS 2024 VS 2031
  • アジア地域 メルカプトプリン錠 収益：地域別 (2020-2031)
  • アジア地域 メルカプトプリン錠 販売：地域別 (2020-2031)
  • 日本
  • 韓国
  • 台湾
  • 東南アジア
  • インド
  • オーストラリア

第10章 中東, アフリカ ・ラテンアメリカ

• 中東, アフリカ ・ラテンアメリカの市場規模：タイプ別
  • 中東, アフリカ ・ラテンアメリカのメルカプトプリン錠 販売：タイプ別 (2020-2031)
  • 中東, アフリカ ・ラテンアメリカのメルカプトプリン錠 収益：タイプ別 (2020-2031)
• 中東, アフリカ ・ラテンアメリカの市場規模：用途別
  • 中東, アフリカ ・ラテンアメリカのメルカプトプリン錠 販売：用途別 (2020-2031)
  • 中東, アフリカ ・ラテンアメリカのメルカプトプリン錠 収益：用途別 (2020-2031)
• 中東, アフリカ ・ラテンアメリカの市場規模：国別
  • 中東, アフリカ ・ラテンアメリカのメルカプトプリン錠の収益：国別: 2020 VS 2024 VS 2031
  • 中東, アフリカ ・ラテンアメリカのメルカプトプリン錠の収益：国別 (2020-2031)
  • 中東, アフリカ ・ラテンアメリカのメルカプトプリン錠の販売：国別 (2020-2031)
  • ブラジル
  • メキシコ
  • トルコ
  • イスラエル
  • 湾岸協力理事会諸国

第11章 企業プロファイル

• Stason Pharmaceuticals
• Dr. Reddy's Laboratories
• Hikma Pharmaceuticals
• Viatris
• Sinopharm
• Zhejiang Hisun Pharmaceutical
• Guangzhou Baiyunshan Guanghua Pharmaceutical
• China Resources Double-Crane Pharmaceutical
• Zhejiang Zhebei Pharmaceutical
• Shaanxi Hantang Pharmaceutical

第12章 業界チェーンと販売チャネルの分析

• メルカプトプリン錠 業界チェーン分析
• メルカプトプリン錠 主要原材料
  • 主要原材料
  • 原材料の主要サプライヤー
• メルカプトプリン錠 生産形態とプロセス
• メルカプトプリン錠 販売およびマーケティング
  • メルカプトプリン錠 販売チャネルs
  • メルカプトプリン錠 卸業者
• メルカプトプリン錠 顧客

第13章 メルカプトプリン錠 市場動向

• メルカプトプリン錠 業界動向
• メルカプトプリン錠 市場の促進要因
• メルカプトプリン錠 市場の課題
• メルカプトプリン錠 市場の抑制要因

第14章 主な調査結果 世界のメルカプトプリン錠の主な市場調査結果

第15章 付録

List of Tables

Table 1. Global Mercaptopurine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Major Manufacturers of 25mg

Table 3. Major Manufacturers of 50mg

Table 4. Global Mercaptopurine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 5. Global Mercaptopurine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 6. Global Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Revenue Market Share by Region (2020-2031)

Table 8. Global Mercaptopurine Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 9. Global Mercaptopurine Tablets Sales by Region (2020-2031) & (K Units)

Table 10. Global Sales Market Share by Region (2020-2031)

Table 11. Global Mercaptopurine Tablets Sales by Manufacturers (2020-2025) & (K Units)

Table 12. Global Mercaptopurine Tablets Sales Share by Manufacturers (2020-2025)

Table 13. Global Mercaptopurine Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 14. Global Mercaptopurine Tablets Revenue Market Share by Manufacturers (2020-2025)

Table 15. Global Key Players of Mercaptopurine Tablets, Industry Ranking, 2023 VS 2024 VS 2024

Table 16. Mercaptopurine Tablets Price by Manufacturers (2020-2025) & (US$/Unit)

Table 17. Global Mercaptopurine Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 18. Global Mercaptopurine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mercaptopurine Tablets as of 2024)

Table 19. Global Key Manufacturers of Mercaptopurine Tablets, Manufacturing Base Distribution and Headquarters

Table 20. Global Key Manufacturers of Mercaptopurine Tablets, Product Offered and Application

Table 21. Global Key Manufacturers of Mercaptopurine Tablets, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Mercaptopurine Tablets Sales by Type (2020-2025) & (K Units)

Table 24. Global Mercaptopurine Tablets Sales by Type (2026-2031) & (K Units)

Table 25. Global Sales Share by Type (2020-2031)

Table 26. Global Mercaptopurine Tablets Revenue by Type (2020-2025) & (US$ Million)

Table 27. Global Mercaptopurine Tablets Revenue by Type (2026-2031) & (US$ Million)

Table 28. Global Revenue Share by Type (2020-2031)

Table 29. Mercaptopurine Tablets Price by Type (2020-2025) & (US$/Unit)

Table 30. Global Mercaptopurine Tablets Price Forecast by Type (2026-2031) & (US$/Unit)

Table 31. Global Mercaptopurine Tablets Sales by Application (2020-2025) & (K Units)

Table 32. Global Mercaptopurine Tablets Sales by Application (2026-2031) & (K Units)

Table 33. Global Sales Share by Application (2020-2031)

Table 34. Global Mercaptopurine Tablets Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Mercaptopurine Tablets Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Revenue Share by Application (2020-2031)

Table 37. Mercaptopurine Tablets Price by Application (2020-2025) & (US$/Unit)

Table 38. Global Mercaptopurine Tablets Price Forecast by Application (2026-2031) & (US$/Unit)

Table 39. US & Canada Sales by Type (2020-2031) & (K Units)

Table 40. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 41. US & Canada Sales by Application (2020-2031) & (K Units)

Table 42. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 43. US & Canada Mercaptopurine Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 45. US & Canada Sales by Country (2020-2031) & (K Units)

Table 46. Europe Sales by Type (2020-2031) & (K Units)

Table 47. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 48. Europe Sales by Application (2020-2031) & (K Units)

Table 49. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 50. Europe Mercaptopurine Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 51. Europe Sales by Country (2020-2031) & (K Units)

Table 52. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 53. China Sales by Type (2020-2031) & (K Units)

Table 54. China Revenue by Type (2020-2031) & (US$ Million)

Table 55. China Sales by Application (2020-2031) & (K Units)

Table 56. China Revenue by Application (2020-2031) & (US$ Million)

Table 57. Asia Sales by Type (2020-2031) & (K Units)

Table 58. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 59. Asia Sales by Application (2020-2031) & (K Units)

Table 60. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 61. Asia Mercaptopurine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 62. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 63. Asia Sales by Region (2020-2031) & (K Units)

Table 64. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Units)

Table 65. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 66. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Units)

Table 67. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 68. Middle East, Africa and Latin America Mercaptopurine Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 69. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 70. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Units)

Table 71. Stason Pharmaceuticals Company Information

Table 72. Stason Pharmaceuticals Description and Major Businesses

Table 73. Stason Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 74. Stason Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

Table 75. Stason Pharmaceuticals Recent Developments

Table 76. Dr. Reddy's Laboratories Company Information

Table 77. Dr. Reddy's Laboratories Description and Major Businesses

Table 78. Dr. Reddy's Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 79. Dr. Reddy's Laboratories Product Model Numbers, Pictures, Descriptions and Specifications

Table 80. Dr. Reddy's Laboratories Recent Developments

Table 81. Hikma Pharmaceuticals Company Information

Table 82. Hikma Pharmaceuticals Description and Major Businesses

Table 83. Hikma Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 84. Hikma Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

Table 85. Hikma Pharmaceuticals Recent Developments

Table 86. Viatris Company Information

Table 87. Viatris Description and Major Businesses

Table 88. Viatris Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 89. Viatris Product Model Numbers, Pictures, Descriptions and Specifications

Table 90. Viatris Recent Developments

Table 91. Sinopharm Company Information

Table 92. Sinopharm Description and Major Businesses

Table 93. Sinopharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 94. Sinopharm Product Model Numbers, Pictures, Descriptions and Specifications

Table 95. Sinopharm Recent Developments

Table 96. Zhejiang Hisun Pharmaceutical Company Information

Table 97. Zhejiang Hisun Pharmaceutical Description and Major Businesses

Table 98. Zhejiang Hisun Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Zhejiang Hisun Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 100. Zhejiang Hisun Pharmaceutical Recent Developments

Table 101. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information

Table 102. Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Major Businesses

Table 103. Guangzhou Baiyunshan Guanghua Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Guangzhou Baiyunshan Guanghua Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 105. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments

Table 106. China Resources Double-Crane Pharmaceutical Company Information

Table 107. China Resources Double-Crane Pharmaceutical Description and Major Businesses

Table 108. China Resources Double-Crane Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. China Resources Double-Crane Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 110. China Resources Double-Crane Pharmaceutical Recent Developments

Table 111. Zhejiang Zhebei Pharmaceutical Company Information

Table 112. Zhejiang Zhebei Pharmaceutical Description and Major Businesses

Table 113. Zhejiang Zhebei Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Zhejiang Zhebei Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Zhejiang Zhebei Pharmaceutical Recent Developments

Table 116. Shaanxi Hantang Pharmaceutical Company Information

Table 117. Shaanxi Hantang Pharmaceutical Description and Major Businesses

Table 118. Shaanxi Hantang Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Shaanxi Hantang Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. Shaanxi Hantang Pharmaceutical Recent Developments

Table 121. Key Raw Materials Lists

Table 122. Raw Materials Key Suppliers Lists

Table 123. Distributors List

Table 124. Customers List

Table 125. Market Trends

Table 126. Market Drivers

Table 127. Market Challenges

Table 128. Market Restraints

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Mercaptopurine Tablets Product Picture

Figure 2. Global Mercaptopurine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Mercaptopurine Tablets Market Share by Type: 2024 & 2031

Figure 4. 25mg Product Picture

Figure 5. 50mg Product Picture

Figure 6. Global Mercaptopurine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Global Mercaptopurine Tablets Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Mercaptopurine Tablets Report Years Considered

Figure 12. Global Mercaptopurine Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 14. Global Mercaptopurine Tablets Revenue by Region (2020-2031) (US$ Million)

Figure 15. Global Mercaptopurine Tablets Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 16. Global Mercaptopurine Tablets Revenue Market Share by Region (2020-2031)

Figure 17. Global Mercaptopurine Tablets Sales (2020-2031) & (K Units)

Figure 18. Global Mercaptopurine Tablets Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 19. Global Mercaptopurine Tablets Sales Market Share by Region (2020-2031)

Figure 20. US & Canada Mercaptopurine Tablets Sales YoY (2020-2031) & (K Units)

Figure 21. US & Canada Mercaptopurine Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 22. Europe Mercaptopurine Tablets Sales YoY (2020-2031) & (K Units)

Figure 23. Europe Mercaptopurine Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 24. China Mercaptopurine Tablets Sales YoY (2020-2031) & (K Units)

Figure 25. China Mercaptopurine Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 26. Asia (excluding China) Mercaptopurine Tablets Sales YoY (2020-2031) & (K Units)

Figure 27. Asia (excluding China) Mercaptopurine Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Mercaptopurine Tablets Sales YoY (2020-2031) & (K Units)

Figure 29. Middle East, Africa and Latin America Mercaptopurine Tablets Revenue YoY (2020-2031) & (US$ Million)

Figure 30. Global Mercaptopurine Tablets Sales Share by Manufacturers (2024)

Figure 31. The Mercaptopurine Tablets Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 32. Global Mercaptopurine Tablets Revenue Share by Manufacturers (2024)

Figure 33. The Top 5 and 10 Largest Manufacturers of Mercaptopurine Tablets in the World: Market Share by Mercaptopurine Tablets Revenue in 2024

Figure 34. Global Mercaptopurine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 35. Global Mercaptopurine Tablets Sales Market Share by Type (2020-2031)

Figure 36. Global Mercaptopurine Tablets Revenue Market Share by Type (2020-2031)

Figure 37. Global Mercaptopurine Tablets Sales Market Share by Application (2020-2031)

Figure 38. Global Mercaptopurine Tablets Revenue Market Share by Application (2020-2031)

Figure 39. US & Canada Mercaptopurine Tablets Sales Market Share by Type (2020-2031)

Figure 40. US & Canada Mercaptopurine Tablets Revenue Market Share by Type (2020-2031)

Figure 41. US & Canada Mercaptopurine Tablets Sales Market Share by Application (2020-2031)

Figure 42. US & Canada Mercaptopurine Tablets Revenue Market Share by Application (2020-2031)

Figure 43. US & Canada Mercaptopurine Tablets Revenue Share by Country (2020-2031)

Figure 44. US & Canada Mercaptopurine Tablets Sales Share by Country (2020-2031)

Figure 45. US Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 46. Canada Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 47. Europe Mercaptopurine Tablets Sales Market Share by Type (2020-2031)

Figure 48. Europe Mercaptopurine Tablets Revenue Market Share by Type (2020-2031)

Figure 49. Europe Mercaptopurine Tablets Sales Market Share by Application (2020-2031)

Figure 50. Europe Mercaptopurine Tablets Revenue Market Share by Application (2020-2031)

Figure 51. Europe Mercaptopurine Tablets Sales Share by Country (2020-2031)

Figure 52. Europe Mercaptopurine Tablets Revenue Share by Country (2020-2031)

Figure 53. Germany Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 54. France Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 55. U.K. Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 56. Italy Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 57. Russia Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 58. China Mercaptopurine Tablets Sales Market Share by Type (2020-2031)

Figure 59. China Mercaptopurine Tablets Revenue Market Share by Type (2020-2031)

Figure 60. China Mercaptopurine Tablets Sales Market Share by Application (2020-2031)

Figure 61. China Mercaptopurine Tablets Revenue Market Share by Application (2020-2031)

Figure 62. Asia Mercaptopurine Tablets Sales Market Share by Type (2020-2031)

Figure 63. Asia Mercaptopurine Tablets Revenue Market Share by Type (2020-2031)

Figure 64. Asia Mercaptopurine Tablets Sales Market Share by Application (2020-2031)

Figure 65. Asia Mercaptopurine Tablets Revenue Market Share by Application (2020-2031)

Figure 66. Asia Mercaptopurine Tablets Revenue Share by Region (2020-2031)

Figure 67. Asia Mercaptopurine Tablets Sales Share by Region (2020-2031)

Figure 68. Japan Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 69. South Korea Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 70. China Taiwan Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 71. Southeast Asia Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 72. India Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 73. Australia Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Mercaptopurine Tablets Sales Market Share by Type (2020-2031)

Figure 75. Middle East, Africa and Latin America Mercaptopurine Tablets Revenue Market Share by Type (2020-2031)

Figure 76. Middle East, Africa and Latin America Mercaptopurine Tablets Sales Market Share by Application (2020-2031)

Figure 77. Middle East, Africa and Latin America Mercaptopurine Tablets Revenue Market Share by Application (2020-2031)

Figure 78. Middle East, Africa and Latin America Mercaptopurine Tablets Revenue Share by Country (2020-2031)

Figure 79. Middle East, Africa and Latin America Mercaptopurine Tablets Sales Share by Country (2020-2031)

Figure 80. Brazil Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 81. Mexico Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 82. Turkey Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 83. Israel Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 84. GCC Countries Mercaptopurine Tablets Revenue (2020-2031) & (US$ Million)

Figure 85. Value Chain

Figure 86. Mercaptopurine Tablets Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

This research report focuses on the Mercaptopurine Tablets Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Mercaptopurine Tablets Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Mercaptopurine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
  • 1.2.2 25mg
  • 1.2.3 50mg
• 1.3 Market by Application
  • 1.3.1 Global Mercaptopurine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Mercaptopurine Tablets Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Revenue by Region
  • 2.2.1 Global Mercaptopurine Tablets Revenue by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Global Mercaptopurine Tablets Revenue by Region (2020-2031)
  • 2.2.3 Global Mercaptopurine Tablets Revenue Market Share by Region (2020-2031)
• 2.3 Global Mercaptopurine Tablets Sales Estimates and Forecasts 2020-2031
• 2.4 Global Sales by Region
  • 2.4.1 Global Mercaptopurine Tablets Sales by Region: 2020 VS 2024 VS 2031
  • 2.4.2 Global Mercaptopurine Tablets Sales by Region (2020-2031)
  • 2.4.3 Global Mercaptopurine Tablets Sales Market Share by Region (2020-2031)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Sales by Manufacturers
  • 3.1.1 Global Mercaptopurine Tablets Sales by Manufacturers (2020-2025)
  • 3.1.2 Global Mercaptopurine Tablets Sales Market Share by Manufacturers (2020-2025)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mercaptopurine Tablets in 2024
• 3.2 Global Revenue by Manufacturers
  • 3.2.1 Global Mercaptopurine Tablets Revenue by Manufacturers (2020-2025)
  • 3.2.2 Global Mercaptopurine Tablets Revenue Market Share by Manufacturers (2020-2025)
  • 3.2.3 Global Top 10 and Top 5 Companies by Mercaptopurine Tablets Revenue in 2024
• 3.3 Global Key Players of Mercaptopurine Tablets, Industry Ranking, 2023 VS 2024
• 3.4 Global Mercaptopurine Tablets Sales Price by Manufacturers (2020-2025)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Mercaptopurine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Mercaptopurine Tablets, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Mercaptopurine Tablets, Product Offered and Application
• 3.8 Global Key Manufacturers of Mercaptopurine Tablets, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Sales by Type
  • 4.1.1 Global Mercaptopurine Tablets Historical Sales by Type (2020-2025)
  • 4.1.2 Global Mercaptopurine Tablets Forecasted Sales by Type (2026-2031)
  • 4.1.3 Global Mercaptopurine Tablets Sales Market Share by Type (2020-2031)
• 4.2 Global Revenue by Type
  • 4.2.1 Global Mercaptopurine Tablets Historical Revenue by Type (2020-2025)
  • 4.2.2 Global Mercaptopurine Tablets Forecasted Revenue by Type (2026-2031)
  • 4.2.3 Global Mercaptopurine Tablets Revenue Market Share by Type (2020-2031)
• 4.3 Global Price by Type
  • 4.3.1 Global Mercaptopurine Tablets Price by Type (2020-2025)
  • 4.3.2 Global Mercaptopurine Tablets Price Forecast by Type (2026-2031)

5 Market Size by Application

• 5.1 Global Sales by Application
  • 5.1.1 Global Mercaptopurine Tablets Historical Sales by Application (2020-2025)
  • 5.1.2 Global Mercaptopurine Tablets Forecasted Sales by Application (2026-2031)
  • 5.1.3 Global Mercaptopurine Tablets Sales Market Share by Application (2020-2031)
• 5.2 Global Revenue by Application
  • 5.2.1 Global Mercaptopurine Tablets Historical Revenue by Application (2020-2025)
  • 5.2.2 Global Mercaptopurine Tablets Forecasted Revenue by Application (2026-2031)
  • 5.2.3 Global Mercaptopurine Tablets Revenue Market Share by Application (2020-2031)
• 5.3 Global Price by Application
  • 5.3.1 Global Mercaptopurine Tablets Price by Application (2020-2025)
  • 5.3.2 Global Mercaptopurine Tablets Price Forecast by Application (2026-2031)

6 US & Canada

• 6.1 US & Canada Market Size by Type
  • 6.1.1 US & Canada Mercaptopurine Tablets Sales by Type (2020-2031)
  • 6.1.2 US & Canada Mercaptopurine Tablets Revenue by Type (2020-2031)
• 6.2 US & Canada Market Size by Application
  • 6.2.1 US & Canada Mercaptopurine Tablets Sales by Application (2020-2031)
  • 6.2.2 US & Canada Mercaptopurine Tablets Revenue by Application (2020-2031)
• 6.3 US & Canada Market Size by Country
  • 6.3.1 US & Canada Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031
  • 6.3.2 US & Canada Mercaptopurine Tablets Revenue by Country (2020-2031)
  • 6.3.3 US & Canada Mercaptopurine Tablets Sales by Country (2020-2031)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Market Size by Type
  • 7.1.1 Europe Mercaptopurine Tablets Sales by Type (2020-2031)
  • 7.1.2 Europe Mercaptopurine Tablets Revenue by Type (2020-2031)
• 7.2 Europe Market Size by Application
  • 7.2.1 Europe Mercaptopurine Tablets Sales by Application (2020-2031)
  • 7.2.2 Europe Mercaptopurine Tablets Revenue by Application (2020-2031)
• 7.3 Europe Market Size by Country
  • 7.3.1 Europe Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031
  • 7.3.2 Europe Mercaptopurine Tablets Sales by Country (2020-2031)
  • 7.3.3 Europe Mercaptopurine Tablets Revenue by Country (2020-2031)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Market Size by Type
  • 8.1.1 China Mercaptopurine Tablets Sales by Type (2020-2031)
  • 8.1.2 China Mercaptopurine Tablets Revenue by Type (2020-2031)
• 8.2 China Market Size by Application
  • 8.2.1 China Mercaptopurine Tablets Sales by Application (2020-2031)
  • 8.2.2 China Mercaptopurine Tablets Revenue by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Market Size by Type
  • 9.1.1 Asia Mercaptopurine Tablets Sales by Type (2020-2031)
  • 9.1.2 Asia Mercaptopurine Tablets Revenue by Type (2020-2031)
• 9.2 Asia Market Size by Application
  • 9.2.1 Asia Mercaptopurine Tablets Sales by Application (2020-2031)
  • 9.2.2 Asia Mercaptopurine Tablets Revenue by Application (2020-2031)
• 9.3 Asia Market Size by Region
  • 9.3.1 Asia Mercaptopurine Tablets Revenue by Region: 2020 VS 2024 VS 2031
  • 9.3.2 Asia Mercaptopurine Tablets Revenue by Region (2020-2031)
  • 9.3.3 Asia Mercaptopurine Tablets Sales by Region (2020-2031)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Mercaptopurine Tablets Sales by Type (2020-2031)
  • 10.1.2 Middle East, Africa and Latin America Mercaptopurine Tablets Revenue by Type (2020-2031)
• 10.2 Middle East, Africa and Latin America Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Mercaptopurine Tablets Sales by Application (2020-2031)
  • 10.2.2 Middle East, Africa and Latin America Mercaptopurine Tablets Revenue by Application (2020-2031)
• 10.3 Middle East, Africa and Latin America Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Mercaptopurine Tablets Revenue by Country: 2020 VS 2024 VS 2031
  • 10.3.2 Middle East, Africa and Latin America Mercaptopurine Tablets Revenue by Country (2020-2031)
  • 10.3.3 Middle East, Africa and Latin America Mercaptopurine Tablets Sales by Country (2020-2031)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Stason Pharmaceuticals
  • 11.1.1 Stason Pharmaceuticals Company Information
  • 11.1.2 Stason Pharmaceuticals Overview
  • 11.1.3 Stason Pharmaceuticals Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.4 Stason Pharmaceuticals Mercaptopurine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Stason Pharmaceuticals Recent Developments
• 11.2 Dr. Reddy's Laboratories
  • 11.2.1 Dr. Reddy's Laboratories Company Information
  • 11.2.2 Dr. Reddy's Laboratories Overview
  • 11.2.3 Dr. Reddy's Laboratories Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.4 Dr. Reddy's Laboratories Mercaptopurine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Dr. Reddy's Laboratories Recent Developments
• 11.3 Hikma Pharmaceuticals
  • 11.3.1 Hikma Pharmaceuticals Company Information
  • 11.3.2 Hikma Pharmaceuticals Overview
  • 11.3.3 Hikma Pharmaceuticals Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.4 Hikma Pharmaceuticals Mercaptopurine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Hikma Pharmaceuticals Recent Developments
• 11.4 Viatris
  • 11.4.1 Viatris Company Information
  • 11.4.2 Viatris Overview
  • 11.4.3 Viatris Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.4.4 Viatris Mercaptopurine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Viatris Recent Developments
• 11.5 Sinopharm
  • 11.5.1 Sinopharm Company Information
  • 11.5.2 Sinopharm Overview
  • 11.5.3 Sinopharm Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.5.4 Sinopharm Mercaptopurine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Sinopharm Recent Developments
• 11.6 Zhejiang Hisun Pharmaceutical
  • 11.6.1 Zhejiang Hisun Pharmaceutical Company Information
  • 11.6.2 Zhejiang Hisun Pharmaceutical Overview
  • 11.6.3 Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.6.4 Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Zhejiang Hisun Pharmaceutical Recent Developments
• 11.7 Guangzhou Baiyunshan Guanghua Pharmaceutical
  • 11.7.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
  • 11.7.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Overview
  • 11.7.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.7.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
• 11.8 China Resources Double-Crane Pharmaceutical
  • 11.8.1 China Resources Double-Crane Pharmaceutical Company Information
  • 11.8.2 China Resources Double-Crane Pharmaceutical Overview
  • 11.8.3 China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.8.4 China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 China Resources Double-Crane Pharmaceutical Recent Developments
• 11.9 Zhejiang Zhebei Pharmaceutical
  • 11.9.1 Zhejiang Zhebei Pharmaceutical Company Information
  • 11.9.2 Zhejiang Zhebei Pharmaceutical Overview
  • 11.9.3 Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.9.4 Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Zhejiang Zhebei Pharmaceutical Recent Developments
• 11.10 Shaanxi Hantang Pharmaceutical
  • 11.10.1 Shaanxi Hantang Pharmaceutical Company Information
  • 11.10.2 Shaanxi Hantang Pharmaceutical Overview
  • 11.10.3 Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.10.4 Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Shaanxi Hantang Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Mercaptopurine Tablets Industry Chain Analysis
• 12.2 Mercaptopurine Tablets Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Mercaptopurine Tablets Production Mode & Process
• 12.4 Mercaptopurine Tablets Sales and Marketing
  • 12.4.1 Mercaptopurine Tablets Sales Channels
  • 12.4.2 Mercaptopurine Tablets Distributors
• 12.5 Mercaptopurine Tablets Customers

13 Mercaptopurine Tablets Market Dynamics

• 13.1 Mercaptopurine Tablets Industry Trends
• 13.2 Mercaptopurine Tablets Market Drivers
• 13.3 Mercaptopurine Tablets Market Challenges
• 13.4 Mercaptopurine Tablets Market Restraints

14 Key Findings in the Global Mercaptopurine Tablets Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer